These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34310402)

  • 1. A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients.
    Martín-Rojas RM; Chasco-Ganuza M; Casanova-Prieto S; Delgado-Pinos VE; Pérez-Rus G; Duque-González P; Sancho M; Díez-Martín JL; Pascual-Izquierdo C
    Blood Coagul Fibrinolysis; 2021 Oct; 32(7):458-467. PubMed ID: 34310402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: Evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy.
    Henry BM; Benoit SW; de Oliveira MHS; Lippi G; Favaloro EJ; Benoit JL
    Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):129-136. PubMed ID: 33270980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19.
    Marco A; Marco P
    J Thromb Thrombolysis; 2021 Aug; 52(2):497-503. PubMed ID: 33866481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients.
    Joly BS; Darmon M; Dekimpe C; Dupont T; Dumas G; Yvin E; Beranger N; Vanhoorelbeke K; Azoulay E; Veyradier A
    J Thromb Haemost; 2021 Sep; 19(9):2193-2198. PubMed ID: 34219357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis.
    Fan BE; Ng J; Chan SSW; Christopher D; Tso ACY; Ling LM; Young BE; Wong LJL; Sum CLL; Tan HT; Ang MK; Lim GH; Ong KH; Kuperan P; Chia YW
    J Thromb Thrombolysis; 2021 Apr; 51(3):663-674. PubMed ID: 33098540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.
    Goshua G; Pine AB; Meizlish ML; Chang CH; Zhang H; Bahel P; Baluha A; Bar N; Bona RD; Burns AJ; Dela Cruz CS; Dumont A; Halene S; Hwa J; Koff J; Menninger H; Neparidze N; Price C; Siner JM; Tormey C; Rinder HM; Chun HJ; Lee AI
    Lancet Haematol; 2020 Aug; 7(8):e575-e582. PubMed ID: 32619411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance.
    Philippe A; Gendron N; Bory O; Beauvais A; Mirault T; Planquette B; Sanchez O; Diehl JL; Chocron R; Smadja DM
    Angiogenesis; 2021 Aug; 24(3):407-411. PubMed ID: 33974165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ADAMTS13-von Willebrand factor axis in COVID-19 patients.
    Mancini I; Baronciani L; Artoni A; Colpani P; Biganzoli M; Cozzi G; Novembrino C; Boscolo Anzoletti M; De Zan V; Pagliari MT; Gualtierotti R; Aliberti S; Panigada M; Grasselli G; Blasi F; Peyvandi F
    J Thromb Haemost; 2021 Feb; 19(2):513-521. PubMed ID: 33230904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients.
    Hoechter DJ; Becker-Pennrich A; Langrehr J; Bruegel M; Zwissler B; Schaefer S; Spannagl M; Hinske LC; Zoller M
    Thromb Res; 2020 Dec; 196():186-192. PubMed ID: 32891904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the von Willebrand factor/ADAMTS13 imbalance to COVID-19 coagulopathy.
    Seth R; McKinnon TAJ; Zhang XF
    Am J Physiol Heart Circ Physiol; 2022 Jan; 322(1):H87-H93. PubMed ID: 34890277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients.
    Rodríguez Rodríguez M; Castro Quismondo N; Zafra Torres D; Gil Alos D; Ayala R; Martinez-Lopez J
    Int J Lab Hematol; 2021 Aug; 43(4):O152-O155. PubMed ID: 33502080
    [No Abstract]   [Full Text] [Related]  

  • 12. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study.
    Johansson PI; Sørensen AM; Perner A; Welling KL; Wanscher M; Larsen CF; Ostrowski SR
    Crit Care; 2011; 15(6):R272. PubMed ID: 22087841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 coagulopathy: An in-depth analysis of the coagulation system.
    Martín-Rojas RM; Pérez-Rus G; Delgado-Pinos VE; Domingo-González A; Regalado-Artamendi I; Alba-Urdiales N; Demelo-Rodríguez P; Monsalvo S; Rodríguez-Macías G; Ballesteros M; Osorio-Prendes S; Díez-Martín JL; Pascual Izquierdo C
    Eur J Haematol; 2020 Dec; 105(6):741-750. PubMed ID: 32749010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
    Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019.
    Doevelaar AAN; Bachmann M; Hölzer B; Seibert FS; Rohn BJ; Bauer F; Witzke O; Dittmer U; Bachmann M; Yilmaz S; Dittmer R; Schneppenheim S; Babel N; Budde U; Westhoff TH
    Crit Care Med; 2021 May; 49(5):e512-e520. PubMed ID: 33591004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation.
    Peigne V; Azoulay E; Coquet I; Mariotte E; Darmon M; Legendre P; Adoui N; Marfaing-Koka A; Wolf M; Schlemmer B; Veyradier A
    Crit Care; 2013 Nov; 17(6):R273. PubMed ID: 24238574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of coagulation disturbances with severity of COVID-19: a longitudinal study.
    Lu H; Chen M; Tang S; Yu W
    Hematology; 2021 Dec; 26(1):656-662. PubMed ID: 34493174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases.
    Habe K; Wada H; Ito-Habe N; Hatada T; Matsumoto T; Ohishi K; Maruyama K; Imai H; Mizutani H; Nobori T
    Thromb Res; 2012 May; 129(5):598-602. PubMed ID: 22070827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis.
    Grandone E; Vimercati A; Sorrentino F; Colaizzo D; Ostuni A; Ceci O; Capozza M; Tiscia G; De Laurenzo A; Mastroianno M; Cappucci F; Fischetti L; Margaglione M; Cicinelli E; Nappi L
    BMC Pregnancy Childbirth; 2022 Feb; 22(1):142. PubMed ID: 35189860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Plasma ADAMTS13 Activity Is Associated with Coagulopathy, Endothelial Cell Damage and Mortality after Severe Paediatric Trauma.
    Russell RT; McDaniel JK; Cao W; Shroyer M; Wagener BM; Zheng XL; Pittet JF
    Thromb Haemost; 2018 Apr; 118(4):676-687. PubMed ID: 29618154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.